• SENSEX 81,592.45
    -318.56 (--0.39%)
  • BANKNIFTY 61,034.10
    -484.40 (--0.79%)
  • NSE
    2,007.60 2,007.60(%)
  • Hitachi Energy
    32,245.70 38,800.00(%)
  • SBI
    1,074.60 933.85(%)
  • TD Power Systems
    685.00 856.00(%)
  • Reliance Industries
    1,351.00 1,611.20(%)
  • Amber Enterp.
    6,909.00 8,970.00(%)
  • Bharti Airtel
    2,123.80 2,174.70(%)
  • Larsen & Toubro
    4,128.70 3,288.65(%)
  • Kalyan Jewellers
    684.95 327.15(%)
  • SBI Funds Mgt.
    512.45 433.55(%)
  • Cupid
    363.25 53.66(%)
  • Apollo Micro Sys
    477.55 477.55(%)
  • M & M
    3,330.00 2,743.15(%)
  • 3M India
    28,259.25 26,400.05(%)
  • Kotak Mah. Bank
    484.00 345.40(%)
  • Bajaj Finance
    1,118.60 1,177.60(%)
  • Cholaman.Inv.&Fn
    1,810.15 1,299.80(%)
  • Netweb Technol.
    4,272.00 5,810.00(%)
  • BLS Polymers
    279.80 288.00(%)
  • Maruti Suzuki
    12,800.00 10,984.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Gujarat Themis Biosyn Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Themis
  • BSE Code : 216.0
  • ISIN : INE942C01045
388.65 1 (0.28%)
  • As on 14 Nov 2026 (EOD)

  • Today’s Low

    380.30

  • Today’s High

    392.35

  • Open

    387.00

  • Perv Close

    387.55

  • 52W Low

    225.05

  • 52W High

    470.05

Key Indicators

  • P/E(TTM)

    104.08

  • Mar.Cap (₹Cr.)

    5,058.35

  • Div & Yield %

    0.14

  • Book Value(₹)

    79.74

  • Debt-Equity Ratio

    0.28

  • AGM Date

    13-Nov-2026

  • EPS

    3.74

  • P/E Ratio

    104.08

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    5,058.35

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    13.02

  • BV (₹)

    79.70

  • Sales( ₹ in Cr.)

    165.82

  • NP (in Cr.)

    46.68

  • NP Var(%)

    -4.0

  • Div%

    67.0

  • CPS (₹)

    4.60

  • EPS (₹)

    3.60

  • Traded Value (₹ in Lakhs)

    5,066.15

  • 52 Week High

    470.05

  • 52 Week Low

    225.05

  • Price BSE

    389.0

  • Price NSE

    389.00

  • Market Capital( in Cr.)

    5,066.15

  • P/C Ratio

    84.90

  • P/E Ratio

    108.50

  • Price Vs.BV

    3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 165.82 150.80 169.82 148.39 114.85 90.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 165.82 150.80 169.82 148.39 114.85 90.56
Other Income 2.43 2.44 4.38 6.59 4.05 3.27
Stock Adjustments 9.03 1.27 -11.01 3.24 5.13 0.38
Total Income 177.28 154.51 163.19 158.22 124.03 94.21
EXPENDITURE :            
Raw Materials 30.43 25.78 25.67 29.73 21.75 15.75
Power and Fuel Cost 31.89 26.63 26.53 26.41 21.73 16.57
Employee Cost 14.99 11.44 10.21 7.75 7.08 7.11
Other Manufacturing Expenses 7.75 9.20 6.79 6.80 7.91 8.79
Selling and Administration Expenses 8.37 5.81 8.59 6.66 2.31 1.86
Miscellaneous Expenses 5.01 4.36 2.29 0.64 1.15 0.53
Employee Benefit Expenses 14.99 11.44 10.21 7.75 7.08 7.11
Less: Preoperative Expenditure 0.00 -0.01 -0.01 0.00 0.00 0.00
Total Expenses 98.43 83.24 80.09 77.99 61.94 50.61
Operating Profit 78.85 71.27 83.10 80.22 62.10 43.59
Interest 3.84 0.36 0.23 0.18 0.83 0.98
Gross Profit 75.01 70.91 82.87 80.04 61.27 42.61
Depreciation 12.92 5.37 3.54 2.58 2.23 1.73
Profit Before Tax 62.09 65.54 79.33 77.46 59.04 40.88
Current Tax 10.79 16.49 19.80 19.24 15.34 10.58
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.62 0.28 0.38 0.26 0.07 0.13
Reported Net Profit 46.68 48.77 59.16 57.97 43.62 30.18
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.01
Adjusted Net Profit 46.68 48.77 59.16 57.97 43.62 30.17
Adjustment below Net Profit 0.01 -1.42 -0.03 0.06 -0.08 -0.03
P & L Balance brought forward 237.33 191.79 139.56 93.74 60.36 32.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 7.30 1.82 6.90 12.20 10.17 2.40
P & L Balance carried down 276.71 237.33 191.79 139.56 93.74 60.36
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 67.00 67.00 100.00 108.00 220.00 0.00
Dividend Per Share(Rs) 0.67 0.67 1.00 5.40 11.00 0.00
Earnings Per Share-Unit Curr 4.28 4.48 8.14 39.90 30.03 20.77
Earnings Per Share(Adj)-Unit Curr 4.28 4.48 5.43 5.32 4.00 2.77
Book Value 26.41 22.79 27.72 102.66 71.11 48.14
Book Value(Adj)-Unit Curr 26.41 22.79 18.48 13.69 9.48 6.42

Shareholding Pattern

  • Promoter Group

    59.33%

  • Public Share Holding

    40.67%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 73,491,287 56.47 73,491,287 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,726,796 2.86 3,726,791 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 77,218,083 59.33 77,218,078 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 750 0.00 750 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 250 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,944,331 3.80 4,944,331 25
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 2,824,859 2.17 2,824,859 1
Mutual Funds / UTI 12,537,004 9.63 12,523,004 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,099,371 0.84 1,089,121 5
Trusts 750 0.00 750 1
Venture Capital Funds 0 0.00 0 0
Sub total 21,407,315 16.45 21,382,815 41
2] Non Institution
Bodies Corporate 6,266,273 4.81 6,239,273 202
Clearing Members 241,982 0.19 241,982 19
Directors of their Relatives 169,770 0.13 169,770 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,342,931 1.03 1,207,681 778
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,342,457 1.03 1,342,457 529
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,405,593 3.39 4,405,593 11
Individuals holding nominal share capital up to Rs. 1 lakh 17,118,498 13.15 16,177,663 27,171
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 250 0.00 0 1
Others 0 0.00 0 0
Sub Total 31,526,307 24.22 30,422,472 28,731
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 130,151,705 100.00 129,023,365 28,781

Company Background

Gujarat Themis Biosyn LtdPharmaceuticals - Indian - Bulk Drugs

  • Gujarat Themis Biosyn Ltd
  • BSE Code : 216.0
  • ISIN : INE942C01045

  • Incorporation Year

    1981

  • Registered Office

    69/C GIDC Industrial Estate
    Valsad Dist, VAPI,
    Gujarat-396195

  • Telephone

    91-260-2430027

  • FAX

    91-260-2400639

  • Chairman

    Dinesh S Patel

  • Managing Director

    Sachin D Patel

  • Company Secretary

    Vineet Gawankar

  • Auditor

    GMJ & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Gujarat Themis Biosyn Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Guj. Themis Bio. 389.25 168.25 165.82 104.08 18.05
Abbott India 26,413.45 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,039.00 2,304.07 2,275.58 84.95 27.86
Sanofi India 3,302.75 1,857.10 1,837.40 20.87 54.17
Glaxosmi. Pharma 2,669.55 3,932.76 3,790.20 39.67 58.17
Evonile Pharma 1,520.30 393.10 354.33 -1,333.60 15.94
Cipla 1,393.00 20,102.60 18,979.95 42.46 13.88
Bliss GVS Pharma 673.00 773.53 729.81 43.87 12.51
Amrutanjan Healt 509.00 520.13 502.55 25.68 24.16
Fermenta Biotec. 473.80 474.15 450.25 22.39 18.77
Ambalal Sarabhai 38.59 19.52 3.94 65.41 6.77